Venture Certified
| 혁신성장유형 | 2021-08-18 ~ 2024-08-17 | 20210818030106 | 2021-08-18 |
| 혁신성장유형 | 2024-08-18 ~ 2027-08-17 | 20241016030098 | 2021-08-18 |
Revenue CAGR +17.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 4.4B | 2.3B | 3.2B |
| Operating Profit | 1.0B | 1.1B | -0.2B |
| Net Profit | 1.0B | 1.3B | -0.3B |
| Total Assets | 10B | 9.2B | 3.8B |
| Total Liabilities | 6.7B | 6.9B | 4.7B |
| Total Equity | 3.3B | 2.3B | -0.9B |
▲ 59.7%
▲ 117.2%
▲ 8.0%
▲ 274.6%
▼ 34.3%
| Name | Position | Role |
|---|---|---|
| 허동녕 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 동대문구",
"ceo_name": "허동녕",
"certificate": [
{
"cert_number": "20210818030106",
"changes": "",
"disclosure_date": "2021-08-18",
"first_cert_date": "2021-08-18",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2021-08-18 ~ 2024-08-17"
},
{
"cert_number": "20241016030098",
"changes": "",
"disclosure_date": "2024-10-16",
"first_cert_date": "2021-08-18",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2024-08-18 ~ 2027-08-17"
}
],
"company_name": "㈜바이오프렌즈",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 10900000,
"cost_of_sales": 91044000,
"current_assets": 120145000,
"current_liabilities": 26898000,
"gross_profit": 226925000,
"net_income": -28218000,
"net_income_bs": -28218000,
"non_current_assets": 262176000,
"non_current_liabilities": 444755000,
"non_operating_expenses": 11666000,
"non_operating_income": 5270000,
"operating_profit": -21822000,
"revenue": 317969000,
"sga_expenses": 248747000,
"total_assets": 382321000,
"total_equity": -89332000,
"total_liabilities": 471653000
},
"2023": {
"capital_stock": 10900000,
"cost_of_sales": 65061000,
"current_assets": 166314000,
"current_liabilities": 13875000,
"gross_profit": 167299000,
"net_income": 133449000,
"net_income_bs": 131712000,
"non_current_assets": 755775000,
"non_current_liabilities": 674029000,
"non_operating_expenses": 59626000,
"non_operating_income": 78778000,
"operating_profit": 114297000,
"revenue": 232360000,
"sga_expenses": 53002000,
"total_assets": 922089000,
"total_equity": 234185000,
"total_liabilities": 687904000
},
"2024": {
"capital_stock": 10900000,
"cost_of_sales": 187027000,
"current_assets": 235133000,
"current_liabilities": 37873000,
"gross_profit": 252320000,
"net_income": 95759000,
"net_income_bs": 94893000,
"non_current_assets": 766857000,
"non_current_liabilities": 635039000,
"non_operating_expenses": 21838000,
"non_operating_income": 17170000,
"operating_profit": 100427000,
"revenue": 439347000,
"sga_expenses": 151893000,
"total_assets": 1001990000,
"total_equity": 329078000,
"total_liabilities": 672912000
}
},
"industry": "디지털 적층 성형기계 제조업",
"investment": [],
"main_products": "3D 프린터, 바이오프린터, 바이오잉크, 골이식재",
"phone": "010-3025-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |